MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1167/iovs.65.14.4

Медицинская библиотека · Investigative ophthalmology & visual science · 2024

Change in Systemic Medication and its Influence on Intraocular Pressure - Results From the Gutenberg Health Study.

Laspas Panagiotis, Hartmann Alica, Scholz Ida, Hoffmann Esther Maria, Khawaja Anthony P, Lackner Karl Johannes, Münzel Thomas, Kerahrodi Jasmin Ghaemi, Schmidtmann Irene, Tüscher Oliver, Schattenberg Jörn Markus, Pfeiffer Norbert, Konstantinides Stavros, Wild Philipp Sebastian, Schuster Alexander Karl-Georg

СтатьяНаблюдательное исследованиеПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

PURPOSE: The purpose of this study was to investigate the relationship between the change in systemic medication and intraocular pressure (IOP) on a population-based level.

METHODS

The Gutenberg Health Study is a population-based prospective observational cohort study in Germany. As part of the baseline examination (2007-2012) and 5-year follow-up examination (2012-2017), IOP was measured by non-contact tonometry. Systemic medication was recorded at both time points. Multivariable regression analyses were carried out to analyze associations. Moreover, we calculated the dose-response relationship for the dosage change of selective beta-blockers with IOP change over 5 years.

RESULTS

The analysis population included 19,161 eyes of 9633 participants. IOP change was lower in participants with new intake of selective beta-blockers (-0.31 mm Hg, P < 0.001) and increased in those with discontinuation of selective beta-blocker intake (+0.28 mm Hg, P = 0.02). Associations between IOP change and statins and calcium channel blockers (CCBs) could be attributed to co-medications. There was a dose-response relationship for change in selective beta-blocker intake and change in IOP (-0.16 mm Hg/100 mg, P = 0.02).

CONCLUSIONS

Use of systemic selective beta-blockers is associated with an IOP change on a population level, whereas the association with other systemic medications on IOP change could be explained by co-medication use or change in blood pressure. Patients undergoing IOP monitoring and management should routinely be asked about changes in systemic medications.

Для цитирования: Laspas Panagiotis, Hartmann Alica, Scholz Ida, Hoffmann Esther Maria, Khawaja Anthony P, Lackner Karl Johannes, Münzel Thomas, Kerahrodi Jasmin Ghaemi, Schmidtmann Irene, Tüscher Oliver, Schattenberg Jörn Markus, Pfeiffer Norbert, Konstantinides Stavros, Wild Philipp Sebastian, Schuster Alexander Karl-Georg. Change in Systemic Medication and its Influence on Intraocular Pressure - Results From the Gutenberg Health Study.. Investigative ophthalmology & visual science. 2024. DOI: 10.1167/iovs.65.14.4.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.